NYSE: NVO - Novo Nordisk A/S

Rentabilidade por seis meses: -40.6%
Rendimento de dividendos: +1.37%
Setor: Healthcare

Cronograma de promoção Novo Nordisk A/S

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Novo Nordisk A/S

Novo Nordisk A/S, медицинская компания, занимается исследованиями, разработками, производством и маркетингом фармацевтической продукции по всему миру. Он работает в двух сегментах: лечение диабета и ожирения и биофармация. Сегмент лечения диабета и ожирения предоставляет продукты в области инсулинов, GLP-1 и родственных систем доставки, пероральных противодиабетических продуктов, ожирения и других хронических заболеваний. Сегмент биофармацевтических препаратов предлагает продукты для лечения гемофилии, нарушений роста и заместительной гормональной терапии.

mais detalhes
Соглашения о сотрудничестве компании с Gilead Sciences, Inc. Novo Nordisk A/S также сотрудничает в исследованиях с Lumen Bioscience, Inc. для изучения стратегий доставки пероральных биопрепаратов для лечения кардиометаболических заболеваний. Компания была основана в 1923 году и имеет штаб-квартиру в Багсверде, Дания.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 1982-01-04
ISIN US6701002056
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета dkk
Див.доход ао 2.01
Дивиденд ао 2.54
Сайт https://www.novonordisk.com
Цена ао 71.73
Alteração de preço por dia: 0% (71.73)
Alteração de preço por semana: -8.96% (78.79)
Alteração de preço por mês: -21.13% (90.95)
Alteração de preço em 3 meses: -18.16% (87.65)
Mudança de preço em seis meses: -40.6% (120.76)
Mudança de preço por ano: -44.14% (128.4)
Mudança de preço em 3 anos: -38.76% (117.13)
Mudança de preço em 5 anos: +26.37% (56.76)
Mudança de preço desde o início do ano: -16.61% (86.02)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 13.46 1
P/BV 29.34 1
P/E 37.37 5
EV/EBITDA 27.8 4
Total: 5.13

Eficiência

Nome Significado Nota
ROA, % 26.61 8
ROE, % 78.53 10
Total: 9.5

Dividendos

Nome Significado Nota
Div yield, % 1.37 3.43
DSI 1 10
Total: 4.88

Obrigação

Nome Significado Nota
Debt/EBITDA 0.1988 10
Total: 9.2

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 90.35 9
Rentabilidade Ebitda, % 96.1 9
Rentabilidade EPS, % 1423.17 10
Total: 9.4
Mais detalhes

Mais detalhes

Instituições Volume Compartilhar, %
Jennison Associates LLC 22527772 0.66
Fisher Asset Management, LLC 14129598 0.41
Renaissance Technologies, LLC 13849335 0.4
Bank of America Corporation 12975409 0.38
FMR, LLC 12663225 0.37
Sarofim, Fayez & Co 11814051 0.34
Morgan Stanley 10614811 0.31
Loomis Sayles & Company, LP 9003325 0.26
Folketrygdfondet 8631264 0.25
Polen Capital Management, LLC 7958444 0.23

ETFCompartilhar, %Rentabilidade para o ano, %Dividendos, %
VanEck Pharmaceutical ETF 9.08269 16.62 2.30355
AdvisorShares Gerber Kawasaki ETF 6.32834 27.66 0.87737
AdvisorShares Dorsey Wright ADR ETF 6.28164 26.28 5.32343
First Trust International Equity Opportunities ETF 4.45684 19.69 1.68071
TrueShares Technology, AI & Deep Learning ETF 4.41282 24.67 0.0924
Amplify CWP International Enhanced Dividend Income ETF 3.08863 10.82 5.69
Pacer Trendpilot International ETF 2.32501 12.96 3.28456
Harbor Long-Term Growers ETF 1.65573 36.96 0.59326
Avantis International Equity ETF 1.60201 6.46 3.80856
Nuveen Growth Opportunities ETF 1.59236 39.89 0.49596
Avantis Responsible International Equity ETF 1.58108 17.44 3.61591
Fidelity Magellan ETF 0.99483 30.14 0.67428
Adaptive Alpha Opportunities ETF 0.90303 25.42 0.92229
Goldman Sachs Innovate Equity ETF 0.73238 29.66 1.20987
Fidelity Blue Chip Growth ETF 0.55204 39.34 0.54012
Avantis International Large Cap Value ETF 0.45602 11.63 4.61762
Fidelity Growth Opportunities ETF 0.45018 32.75 0.48881
Dimensional International Core Equity 2 ETF 0.36038 6.52 3.69996
First Trust BuyWrite Income ETF 0.3512 14.09 2.11702
Fidelity New Millennium ETF 0.32428 6.86 1.58241
T. Rowe Price U.S. Equity Research ETF 0.17619 33.32 1.24191
Dimensional International High Profitability ETF 0.14782 3.11 3.08445
Dimensional International Core Equity Market ETF 0.1062 13.09 3.48343
Dimensional World ex U.S. Core Equity 2 ETF 0.09575 13.06 3.62488
Dimensional International Value ETF 0.00342 12.76 5.00468
1.9220.452.4



Supervisor Cargo Pagamento Ano de nascimento
Mr. Lars Fruergaard Jorgensen President, CEO & Member of Management Board 4.67M 1966 (59 anos)
Mr. Karsten Munk Knudsen Executive VP, CFO & Member of the Management Board 1.85M 1971 (54 ano)
Mr. Henrik Ehlers Wulff Executive VP of Product Supply, Quality & IT and Member of the Management Board 1.87M 1970 (55 anos)
Ms. Camilla Sylvest Executive VP of Commercial Strategy & Corporate Affairs and Member of the Management Board 1.82M 1972 (53 ano)
Mr. Maziar Mike Doustdar Executive VP of International Operations & Member of the Management Board N/A 1970 (55 anos)
Mr. Douglas J. Langa Executive VP of North America Operations & Member of Management Board N/A 1966 (59 anos)
Mr. Ludovic Helfgott Executive VP, Head of Rare Disease & Member of Management Board N/A 1974 (51 ano)
Dr. Martin Holst Lange Executive VP of Development & Member of the Management Board 1.77M 1970 (55 anos)
Dr. Marcus Schindler Ph.D. EVP of Research & Early Development, Chief Scientific Officer & Member of the Management Board 1.77M 1966 (59 anos)
Ms. Tania Sabroe Executive VP of Global People & Organisation and Member of Management Board N/A 1977 (48 anos)

Endereço: Denmark, Bagsvaerd, Novo Alle 1 - abrir no Google Maps, abrir mapas Yandex
Site: https://www.novonordisk.com